Cationic liposomes as gene delivery system: transfection efficiency and new application.

As it has been generally reported that oppositely charged cationic liposomes (CLs) are superior to either neutral or anionic liposomes as gene delivery carrier, interest in the properties, structures, transfection mechanism of CLs and so forth arises unprecedentedly. However, our understanding about the mechanism of CLs-gene complexes (lipoplex)-cell interaction and factors influencing the transfection efficiency (TE) of CLs remains poor. In this article, we describe some new results aimed at elucidating the relationship between the chemical-physical properties of lipoplex with TE and introducing recent applications of CLs in gene therapy.

[1]  Rob Lambkin-Williams,et al.  Immunogenicity, protective efficacy and mechanism of novel CCS adjuvanted influenza vaccine. , 2010, Vaccine.

[2]  Yvonne Perrie,et al.  Liposomal cationic charge and antigen adsorption are important properties for the efficient deposition of antigen at the injection site and ability of the vaccine to induce a CMI response. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[3]  Li Yang,et al.  Co-delivery of doxorubicin and plasmid by a novel FGFR-mediated cationic liposome. , 2010, International journal of pharmaceutics.

[4]  Jeong-Sook Park,et al.  Enhanced siRNA delivery using cationic liposomes with new polyarginine-conjugated PEG-lipid. , 2010, International journal of pharmaceutics.

[5]  H. Tsukada,et al.  T cell-independent B cell response is responsible for ABC phenomenon induced by repeated injection of PEGylated liposomes. , 2010, International journal of pharmaceutics.

[6]  Yi-Hui Deng,et al.  Effects of cleavable PEG-cholesterol derivatives on the accelerated blood clearance of PEGylated liposomes. , 2010, Biomaterials.

[7]  Yang Zhang,et al.  DC-Chol/DOPE cationic liposomes: a comparative study of the influence factors on plasmid pDNA and siRNA gene delivery. , 2010, International journal of pharmaceutics.

[8]  Andrew D. Miller,et al.  DODAG; a versatile new cationic lipid that mediates efficient delivery of pDNA and siRNA. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[9]  S. Simões,et al.  Physicochemical properties of transferrin-associated lipopolyplexes and their role in biological activity. , 2010, Colloids and surfaces. B, Biointerfaces.

[10]  S. Simões,et al.  Design of peptide-targeted liposomes containing nucleic acids. , 2010, Biochimica et biophysica acta.

[11]  P. Dario,et al.  Evaluation of cationic liposomes composed of an amino acid-based lipid for neuronal transfection. , 2010, Nanomedicine : nanotechnology, biology, and medicine.

[12]  N. Ali,et al.  Comparison of liposome based antigen delivery systems for protection against Leishmania donovani. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[13]  W. Radchatawedchakoon,et al.  Solid phase synthesis of novel asymmetric hydrophilic head cholesterol-based cationic lipids with potential DNA delivery. , 2010, Bioorganic & medicinal chemistry.

[14]  A. Noël,et al.  Antiangiogenic liposomal gene therapy with 16K human prolactin efficiently reduces tumor growth. , 2009, Cancer letters.

[15]  M. H. Santana,et al.  The synergy between structural stability and DNA-binding controls the antibody production in EPC/DOTAP/DOPE liposomes and DOTAP/DOPE lipoplexes. , 2009, Colloids and surfaces. B, Biointerfaces.

[16]  M. Brgles,et al.  Liposome fusogenicity and entrapment efficiency of antigen determine the Th1/Th2 bias of antigen-specific immune response. , 2009, Vaccine.

[17]  T. Ishida,et al.  Effect of siRNA in PEG-coated siRNA-lipoplex on anti-PEG IgM production. , 2009, Journal of controlled release : official journal of the Controlled Release Society.

[18]  M. Ramezani,et al.  The influence of size, lipid composition and bilayer fluidity of cationic liposomes on the transfection efficiency of nanolipoplexes. , 2009, Colloids and surfaces. B, Biointerfaces.

[19]  S. Simões,et al.  Cationic liposome-DNA complexes as gene delivery vectors: Development and behaviour towards bone-like cells. , 2009, Acta biomaterialia.

[20]  T. Ishida,et al.  Oxaliplatin encapsulated in PEG-coated cationic liposomes induces significant tumor growth suppression via a dual-targeting approach in a murine solid tumor model. , 2009, Journal of controlled release : official journal of the Controlled Release Society.

[21]  K. Cheng,et al.  Transcutaneous immunization by lipoplex-patch based DNA vaccines is effective vaccination against Japanese encephalitis virus infection. , 2009, Journal of controlled release : official journal of the Controlled Release Society.

[22]  R. C.-Gaudreault,et al.  Spectroscopic characterization of DMPC/DOTAP cationic liposomes and their interactions with DNA and drugs. , 2009, Chemistry and physics of lipids.

[23]  Joseph Rosenecker,et al.  Current prospects for mRNA gene delivery. , 2009, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[24]  C. Cametti,et al.  Comparison of different commercially available cationic liposome-DNA lipoplexes: Parameters influencing toxicity and transfection efficiency. , 2009, Colloids and surfaces. B, Biointerfaces.

[25]  Minhyung Lee,et al.  Nanosphere-mediated delivery of vascular endothelial growth factor gene for therapeutic angiogenesis in mouse ischemic limbs. , 2008, Biomaterials.

[26]  N. Plesnila,et al.  Tf-lipoplexes for neuronal siRNA delivery: a promising system to mediate gene silencing in the CNS. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[27]  T. Anchordoquy,et al.  Cholesterol domains in cationic lipid/DNA complexes improve transfection. , 2008, Biochimica et biophysica acta.

[28]  Vinay S. Sharma,et al.  Synthetic polymeric vectors in gene therapy , 2008 .

[29]  T. Mayumi,et al.  In vitro and in vivo tumor suppressive activity induced by human telomerase transcriptase-targeting antisense oligonucleotides mediated by cationic liposomes. , 2008, Journal of bioscience and bioengineering.

[30]  G. De Rosa,et al.  Novel cationic liposome formulation for the delivery of an oligonucleotide decoy to NF-kappaB into activated macrophages. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[31]  Qiang Zhang,et al.  Increase of the pharmacological and pharmacokinetic efficacy of negatively charged polypeptide recombinant hirudin in rats via parenteral route by association with cationic liposomes. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[32]  S. Takeoka,et al.  Evaluation of cationic assemblies constructed with amino acid based lipids for plasmid DNA delivery. , 2008, Bioconjugate chemistry.

[33]  Y. Maitani,et al.  Hydroxyethylated cationic cholesterol derivatives in liposome vectors promote gene expression in the lung. , 2008, International journal of pharmaceutics.

[34]  T. Ishida,et al.  Accelerated blood clearance (ABC) phenomenon upon repeated injection of PEGylated liposomes. , 2008, International journal of pharmaceutics.

[35]  H. Faneca,et al.  Synergistic antitumoral effect of vinblastine and HSV-Tk/GCV gene therapy mediated by albumin-associated cationic liposomes. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[36]  Andrew D. Miller Towards Safe Nanoparticle Technologies for Nucleic Acid Therapeutics , 2008, Tumori.

[37]  K. Braeckmans,et al.  A fast and sensitive method for measuring the integrity of siRNA-carrier complexes in full human serum. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[38]  Lu Li,et al.  Downregulation of Sirt1 by antisense oligonucleotides induces apoptosis and enhances radiation sensitization in A549 lung cancer cells. , 2007, Lung cancer.

[39]  Y. Maitani,et al.  Cationic liposome (DC-Chol/DOPE=1:2) and a modified ethanol injection method to prepare liposomes, increased gene expression. , 2007, International journal of pharmaceutics.

[40]  G. Damonte,et al.  Lack of mutagenicity and clastogenicity of PNAEmu-NLS targeted to a regulatory sequence of the translocated c-myc oncogene in Burkitt's lymphoma. , 2007, Mutation research.

[41]  K. Braeckmans,et al.  Pegylation of liposomes favours the endosomal degradation of the delivered phosphodiester oligonucleotides. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[42]  T. Nagai,et al.  Mechanisms of co-modified liver-targeting liposomes as gene delivery carriers based on cellular uptake and antigens inhibition effect. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[43]  A. Masotti,et al.  The analysis of serum effects on structure, size and toxicity of DDAB-DOPE and DC-Chol-DOPE lipoplexes contributes to explain their different transfection efficiency. , 2006, Colloids and surfaces. B, Biointerfaces.

[44]  Z. Sideratou,et al.  Factors mediating lipofection potency of a series of cationic phosphonolipids in human cell lines. , 2006, Biochimica et biophysica acta.

[45]  K. Braeckmans,et al.  Delivery of phosphodiester oligonucleotides: can DOTAP/DOPE liposomes do the trick? , 2006, Biochemistry.

[46]  R. Mahato Water insoluble and soluble lipids for gene delivery. , 2005, Advanced drug delivery reviews.

[47]  Y. Barenholz,et al.  Nanostructure of cationic lipid-oligonucleotide complexes. , 2004, Biophysical journal.

[48]  Martin C Garnett,et al.  The effect of poly(ethylene glycol) molecular architecture on cellular interaction and uptake of DNA complexes. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[49]  R. Debs,et al.  The effect of liposome size on the final lipid/DNA ratio of cationic lipoplexes. , 2004, Biophysical journal.

[50]  M. Hope,et al.  Characterization of the inhibitory effect of PEG-lipid conjugates on the intracellular delivery of plasmid and antisense DNA mediated by cationic lipid liposomes. , 2002, Biochimica et biophysica acta.

[51]  Y. Barenholz,et al.  Interplay in lipoplexes between type of pDNA promoter and lipid composition determines transfection efficiency of human growth hormone in NIH3T3 cells in culture. , 2001, Biochimica et biophysica acta.

[52]  A. Urtti,et al.  A lipid carrier with a membrane active component and a small complex size are required for efficient cellular delivery of anti-sense phosphorothioate oligonucleotides. , 2000, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[53]  Düzgüneş,et al.  Mechanisms and kinetics of liposome-cell interactions. , 1999, Advanced drug delivery reviews.

[54]  J. Birchall,et al.  Physico-chemical characterisation and transfection efficiency of lipid-based gene delivery complexes. , 1999, International journal of pharmaceutics.

[55]  F. Szoka,et al.  Cationic lipids are essential for gene delivery mediated by intravenous administration of lipoplexes , 1999, Gene Therapy.

[56]  Simon C Watkins,et al.  Dynamic changes in the characteristics of cationic lipidic vectors after exposure to mouse serum: implications for intravenous lipofection , 1999, Gene Therapy.

[57]  P. Ross,et al.  Lipoplex size is a major determinant of in vitro lipofection efficiency , 1999, Gene Therapy.

[58]  T Salditt,et al.  An inverted hexagonal phase of cationic liposome-DNA complexes related to DNA release and delivery. , 1998, Science.

[59]  T. Yotsuyanagi,et al.  [Cationic liposomes in gene delivery]. , 1998, Nihon rinsho. Japanese journal of clinical medicine.

[60]  O. Zelphati,et al.  Analytical methods for the characterization of cationic lipid-nucleic acid complexes. , 1998, Human gene therapy.

[61]  T. Anchordoquy,et al.  Maintenance of transfection rates and physical characterization of lipid/DNA complexes after freeze-drying and rehydration. , 1997, Archives of biochemistry and biophysics.

[62]  J. Legendre,et al.  Gene transfer mediated by cationic lipids: lack of a correlation between lipid mixing and transfection. , 1997, Biochimica et biophysica acta.

[63]  Joachim O. Rädler,et al.  Structure of DNA-Cationic Liposome Complexes: DNA Intercalation in Multilamellar Membranes in Distinct Interhelical Packing Regimes , 1997, Science.

[64]  K. Mechtler,et al.  Activation of the complement system by synthetic DNA complexes: a potential barrier for intravenous gene delivery. , 1996, Human gene therapy.

[65]  Xiang Gao,et al.  Cationic liposome-mediated gene transfer. , 1995, Gene therapy.

[66]  H. Farhood,et al.  The role of dioleoyl phosphatidylethanolamine in cationic liposome mediated gene transfer. , 1995, Biochimica et biophysica acta.

[67]  I. Verma,et al.  Cationic liposome-mediated RNA transfection. , 1993, Methods in enzymology.

[68]  J. Northrop,et al.  Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[69]  G. J. Dimitriadis Translation of rabbit globin mRNA introduced by liposomes into mouse lymphocytes , 1978, Nature.

[70]  G Poste,et al.  Fusion of mammalian cells by unilamellar lipid vesicles: inflluence of lipid surface charge, fluidity and cholesterol. , 1973, Biochimica et biophysica acta.